Brief: Nona Biosciences Enters Into A Global License Agreement With Pfizer

HBM Holdings

14/12/2023 23:36

Dec 14 (Reuters) - Hbm Holdings Ltd  2142.HK :
    * NONA BIOSCIENCES ENTERS INTO A GLOBAL LICENSE AGREEMENT
WITH
PFIZER FOR HBM9033, AN MSLN-TARGETED ANTIBODY-DRUG CONJUGATE
(ADC)
    * NONA BIOSCIENCES - WILL RECEIVE A TOTAL OF UP TO $53
MILLION IN
UPFRONT AND NEAR-TERM PAYMENTS UNDER DEAL
    * NONA BIOSCIENCES: POTENTIAL FOR MILESTONES OF UP TO $1.05
BILLION PLUS ROYALTIES
    * NONA BIOSCIENCES: ALSO ELIGIBLE TO RECEIVE TIERED
ROYALTIES ON
NET SALES RANGING FROM HIGH SINGLE DIGITS TO HIGH TEENS

Source text for Eikon:  ID:nPn5KL5NVa 
Further company coverage:  2142.HK 

 ((Reuters.Briefs@thomsonreuters.com;))